- Home
- Publications
- Publication Search
- Publication Details
Title
Parkinson's disease: emerging pharmacotherapy
Authors
Keywords
-
Journal
EXPERT OPINION ON EMERGING DRUGS
Volume 13, Issue 4, Pages 573-591
Publisher
Informa Healthcare
Online
2008-12-03
DOI
10.1517/14728210802596906
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Memantine Treatment in Patients with Mild to Moderate Alzheimer's Disease: Results of a Randomised, Double-Blind, Placebo-Controlled 6-Month Study
- (2017) S. Bakchine et al. JOURNAL OF ALZHEIMERS DISEASE
- Depressive illness in Parkinson’s disease – indication of a more advanced and widespread neurodegenerative process?
- (2008) S. E. Pålhagen et al. ACTA NEUROLOGICA SCANDINAVICA
- Adenosine A2Areceptor antagonist istradefylline (KW-6002) reduces “off” time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)
- (2008) Peter A. LeWitt et al. ANNALS OF NEUROLOGY
- The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease
- (2008) T. Pan et al. BRAIN
- L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension
- (2008) Christopher J. Mathias CLINICAL AUTONOMIC RESEARCH
- Non-motor symptoms in Parkinson’s disease
- (2008) W. Poewe EUROPEAN JOURNAL OF NEUROLOGY
- Progress in neuroprotection in Parkinson’s disease
- (2008) A. H. V. Schapira EUROPEAN JOURNAL OF NEUROLOGY
- Loss of thalamic serotonin transporters in early drug-naïve Parkinson’s disease patients is associated with tremor: an [123I]β-CIT SPECT study
- (2008) V. Caretti et al. JOURNAL OF NEURAL TRANSMISSION
- Parkinson's disease: clinical features and diagnosis
- (2008) J Jankovic JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Continuous and Intermittent Nicotine Treatment Reduces L-3,4-Dihydroxyphenylalanine (L-DOPA)-Induced Dyskinesias in a Rat Model of Parkinson's Disease
- (2008) T. Bordia et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
- Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: A double-blind, randomized, placebo-controlled study
- (2008) David Devos et al. MOVEMENT DISORDERS
- Molecular mechanisms of L-DOPA-induced dyskinesia
- (2008) Peter Jenner NATURE REVIEWS NEUROSCIENCE
- Invited Article: Nervous system pathology in sporadic Parkinson disease
- (2008) H. Braak et al. NEUROLOGY
- Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD
- (2008) R. Katzenschlager et al. NEUROLOGY
- A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease
- (2008) M. Stacy et al. NEUROLOGY
- A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model
- (2008) K VANOVER et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Regulation of DARPP-32 phosphorylation by Δ9-tetrahydrocannabinol
- (2007) Anders Borgkvist et al. NEUROPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started